Elsevier

Annals of Oncology

Volume 29, Supplement 8, October 2018, Pages viii743-viii744
Annals of Oncology

Late-breaking and deferred publication abstracts
NSCLC, metastatic
LBA54 - IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

https://doi.org/10.1093/annonc/mdy424.066Get rights and content
Under an Elsevier user license
open archive

Cited by (0)